Diego Kaen

7.7k total citations
12 papers, 115 citations indexed

About

Diego Kaen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Diego Kaen has authored 12 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Diego Kaen's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Research Studies (3 papers). Diego Kaen is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Research Studies (3 papers). Diego Kaen collaborates with scholars based in Argentina, United States and France. Diego Kaen's co-authors include C.H. Barrios, David Cameron, Livia Andrade, Joyce O’Shaughnessy, Kenneth Russell, Andreas Schneeweiß, L. Morales, Margarita Donica, Joseph Gligorov and Semiglazov Vf and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Diego Kaen

11 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Kaen Argentina 4 87 44 27 24 23 12 115
Bronwyn D. Mixter United States 4 70 0.8× 34 0.8× 30 1.1× 18 0.8× 17 0.7× 5 100
Emmanuel S. Antonarakis United States 6 63 0.7× 51 1.2× 27 1.0× 40 1.7× 12 0.5× 29 98
Salvatore Intagliata Italy 5 61 0.7× 49 1.1× 26 1.0× 41 1.7× 13 0.6× 10 100
Cathy Schilero United States 6 57 0.7× 36 0.8× 21 0.8× 33 1.4× 34 1.5× 13 113
Andrew Mant Australia 7 88 1.0× 32 0.7× 27 1.0× 43 1.8× 36 1.6× 16 130
Xinjun Liang China 5 36 0.4× 21 0.5× 18 0.7× 39 1.6× 32 1.4× 11 96
Matteo Duca Italy 5 81 0.9× 57 1.3× 15 0.6× 40 1.7× 36 1.6× 18 143
Adrianna A. Mendes United States 4 74 0.9× 75 1.7× 27 1.0× 31 1.3× 48 2.1× 10 130
Jonathan Grivel France 7 114 1.3× 55 1.3× 22 0.8× 45 1.9× 60 2.6× 9 171
Patricia Lorenzini United States 4 88 1.0× 86 2.0× 17 0.6× 45 1.9× 13 0.6× 11 117

Countries citing papers authored by Diego Kaen

Since Specialization
Citations

This map shows the geographic impact of Diego Kaen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Kaen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Kaen more than expected).

Fields of papers citing papers by Diego Kaen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Kaen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Kaen. The network helps show where Diego Kaen may publish in the future.

Co-authorship network of co-authors of Diego Kaen

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Kaen. A scholar is included among the top collaborators of Diego Kaen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Kaen. Diego Kaen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Aguirre, Elena, Diego Enrico, Diego Kaen, et al.. (2023). P2.18-04 Real-world Study on Efficacy of First-Line Nivolumab + Ipilimumab in Unresectable Malignant Pleural Mesothelioma (ImmunoMeso). Journal of Thoracic Oncology. 18(11). S382–S382. 1 indexed citations
2.
Kaen, Diego, et al.. (2021). Immunotherapy in Lung Cancer: Are the Promises of Long-Term Benefit Finally Met?. Advances in experimental medicine and biology. 1342. 113–142. 5 indexed citations
3.
Kaen, Diego, Lorena Lupinacci, Manglio Rizzo, et al.. (2021). P84.22 Outcomes of TKI Treatment in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Real-World Study in Argentina. Journal of Thoracic Oncology. 16(3). S667–S668. 1 indexed citations
4.
5.
Raez, Luis E., R Caiña Ruiz, Brian Hunis, et al.. (2019). P2.21 Clinical Responses and Survival in Hispanic Patients vs Non-Hispanic White Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy. Journal of Thoracic Oncology. 14(11). S1193–S1194.
6.
Zarbá, Juan José, et al.. (2018). Safety and effectiveness of bevacizumab plus chemotherapy in patients with advanced cervical cancer in real world practice in Argentina.. Journal of Clinical Oncology. 36(15_suppl). e17500–e17500. 1 indexed citations
7.
Arrieta, Óscar, Gonzalo Recondo, Diego Kaen, et al.. (2015). Real-World Patient Characteristics, Treatment Patterns, and Survival among Locally-Advanced/Metastatic Alk+ Non-Small Cell Lung Cancer Patients in Latin America. Value in Health. 18(7). A817–A817. 1 indexed citations
8.
Riggio, Marina, María May, María Jimena Rodriguez, et al.. (2015). Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression. Oncotarget. 6(26). 22081–22097. 24 indexed citations
9.
Wakelee, Heather A., Zanete Zvirbule, Filippo de Braud, et al.. (2014). Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821). International Journal of Radiation Oncology*Biology*Physics. 90(5). S37–S38. 3 indexed citations
10.
Kaen, Diego, Rubén Dario Kowalyszyn, Marcela Carballido, et al.. (2012). F-box and WD repeat domain-containing 7 (FBXW7) mRNA and outcome in biliary tract cancer.. Journal of Clinical Oncology. 30(15_suppl). e14521–e14521. 1 indexed citations
11.
Balañá, Carmen, Cristina Carrato, Mireia Berdiel‐Acer, et al.. (2008). Concordance and clinical value of the MGMT promoter methylation pattern in tissue with paired serum and MGMT protein expression in a series of glioblastoma (GB) patients. Journal of Clinical Oncology. 26(15_suppl). 2037–2037. 1 indexed citations
12.
Rosell, Rafael, et al.. (2007). Age-Related Genetic Abnormalities: The Achilles‘ Heel for Customizing Therapy in Elderly Lung Cancer Patients. Personalized Medicine. 4(1). 59–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bronwyn D. Mixter Breakdown of academic impact, for papers by Emmanuel S. Antonarakis Breakdown of academic impact, for papers by Salvatore Intagliata Breakdown of academic impact, for papers by Cathy Schilero Breakdown of academic impact, for papers by Andrew Mant Breakdown of academic impact, for papers by Xinjun Liang Breakdown of academic impact, for papers by Matteo Duca Breakdown of academic impact, for papers by Adrianna A. Mendes Breakdown of academic impact, for papers by Jonathan Grivel Breakdown of academic impact, for papers by Patricia Lorenzini
Rankless by CCL
2026